FDA product code IBG: Trypsin

IBG is the FDA product code for trypsin. It is a Class I device, regulated under 21 CFR 864.4400 and reviewed by the Pathology panel. FDA has cleared 2 510(k) submissions under IBG, from 2 different applicants. The average 510(k) review took 34 days (median 34). FDA has posted 1 recall for IBG devices.

Classification

FieldValue
Device nameTrypsin
Device classClass I
Regulation21 CFR 864.4400
Review panelPA — Pathology
Medical specialtyPathology
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every IBG clearance

Top IBG applicants

ApplicantClearancesLatest
Oxoid U.S.A., Inc.11980-11-12
Flow Laboratories, Inc.11977-11-22

Most recent IBG clearances

510(k)ApplicantDeviceDecision dateReview days
K802493Oxoid U.S.A., Inc.SPUTASOL1980-11-1233
K771955Flow Laboratories, Inc.TRYPSIN 1%1977-11-2236

Recalls for IBG devices

1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2018-08-02.

YearRecalls
20181

Frequently asked questions

What is FDA product code IBG?

IBG is the FDA product code for trypsin. It is a Class I device, regulated under 21 CFR 864.4400 and reviewed by the Pathology panel.

What device class is IBG?

Class I, regulation 21 CFR 864.4400. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code IBG?

Across 2 cleared submissions the average was 34 days from receipt to decision (median 34).

Which companies have the most IBG clearances?

Oxoid U.S.A., Inc. (1); Flow Laboratories, Inc. (1).

Have IBG devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2018-08-02.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times